chr3-169084946-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_004991.4(MECOM):c.3683C>T(p.Ala1228Val) variant causes a missense change. The variant allele was found at a frequency of 0.0000291 in 1,613,944 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_004991.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152132Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251312Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135816
GnomAD4 exome AF: 0.0000294 AC: 43AN: 1461812Hom.: 0 Cov.: 30 AF XY: 0.0000303 AC XY: 22AN XY: 727204
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152132Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74308
ClinVar
Submissions by phenotype
not specified Uncertain:1
DNA sequence analysis of the MECOM gene demonstrated a sequence change, c.3119C>T, in exon 16 that results in an amino acid change, p.Ala1040Val. This sequence change has been described in the gnomAD database with a frequency of 0.0056% in the Latino/Admixed American subpopulation (dbSNP rs779316050). The p.Ala1040Val change affects a moderately conserved amino acid residue located in a domain of the MECOM protein that is not known to be functional. In-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD, REVEL) provide contradictory results for the p.Ala1040Val substitution. This sequence change does not appear to have been previously described in individuals with MECOM-related disorders. Due to insufficient evidences and the lack of functional studies, the clinical significance of the p.Ala1040Val change remains unknown at this time -
Inborn genetic diseases Uncertain:1
The p.A1228V variant (also known as c.3683C>T), located in coding exon 17 of the MECOM gene, results from a C to T substitution at nucleotide position 3683. The alanine at codon 1228 is replaced by valine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear. -
not provided Uncertain:1
This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 1040 of the MECOM protein (p.Ala1040Val). This variant is present in population databases (rs779316050, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with MECOM-related conditions. ClinVar contains an entry for this variant (Variation ID: 1338059). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at